Paradigm Strategies in Wealth Management LLC Has $565,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Paradigm Strategies in Wealth Management LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 28.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,116 shares of the healthcare conglomerate’s stock after purchasing an additional 245 shares during the period. UnitedHealth Group accounts for approximately 0.4% of Paradigm Strategies in Wealth Management LLC’s investment portfolio, making the stock its 29th biggest position. Paradigm Strategies in Wealth Management LLC’s holdings in UnitedHealth Group were worth $565,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in UNH. State Street Corp raised its stake in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after purchasing an additional 318,039 shares during the period. Franklin Resources Inc. increased its holdings in UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its stake in shares of UnitedHealth Group by 0.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after acquiring an additional 21,149 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on UNH shares. KeyCorp began coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Two equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Trading Down 0.1 %

NYSE UNH opened at $543.21 on Thursday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business’s fifty day moving average is $554.45 and its 200-day moving average is $563.12. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a market capitalization of $499.91 billion, a price-to-earnings ratio of 35.39, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business posted $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.